NAFDAC Alerts Public on Counterfeit Cancer Drugs Avastin and Tecentriq in Nigeria

Patients and healthcare providers urged to verify sources amid rising circulation of fake cancer medicines

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public warning over counterfeit batches of the cancer medications Avastin and Tecentriq circulating in Nigeria. The agency says these fake drugs pose serious health risks and could compromise treatment outcomes for patients battling cancer.

Healthcare providers, pharmacies, and patients are strongly advised to purchase medicines only from licensed and verified distributors. Any suspicious products should be reported immediately to NAFDAC for investigation. The agency also urged heightened vigilance, stressing that counterfeit medications can look identical to genuine products, making verification crucial.
ADS

NAFDAC continues to monitor the situation closely and is collaborating with law enforcement and healthcare stakeholders to prevent the further circulation of these dangerous counterfeit drugs. Patients are encouraged to consult their doctors before starting or continuing treatment if there is any doubt about the authenticity of their medication.

Post a Comment

Previous Post Next Post